Blood test may reveal hidden heart risks in valve disease patients

NCT ID NCT07209631

Completed Knowledge-focused Sponsor: Sohag University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 100 patients with aortic valve sclerosis (a stiffening of the heart valve) and chest pain to see if a blood fat called lipoprotein(a) is linked to the severity of blocked heart arteries. Researchers measured Lp(a) levels from blood samples and compared them to the patients' coronary artery disease severity. The goal was to determine if Lp(a) is just a marker or a useful predictor of heart disease in these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If the link is confirmed, it could help doctors use a simple blood test to better assess heart disease risk in patients with aortic valve sclerosis.
What could go wrong: This is a small, completed observational study, not a treatment trial. The findings may not apply to broader populations or change current medical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC VALVE SCLEROSIS CORONARY ARTERY DISEASE LIPOPROTEIN(A) SERUM SEVERITY

Contacts and locations

Locations

Sohag University

Sohag, 82511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.